RAB42 and neoplasm: These results support the recent findings that RAB42 may act as a pro-oncoprotein that promotes tumor progression, reshapes tumor microenvironment, and could be a new diagnostic and therapeutic marker for LIHC (Paul and Mukherjee, 1986; Kong et al., 2023).